Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Templeton

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Seminars in Hematology|April 1, 1990
Studies of the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one in thalassemia patientsN F Olivieri, G Koren, P St Louis, et al.
Annals of the New York Academy of Sciences|January 1, 1990
Evaluation of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron-loaded patientsN F Olivieri, D M Templeton, G Koren, et al.
Toxicology and Applied Pharmacology|January 12, 1999
Absorption and retention of nickel from drinking water in relation to food intake and nickel sensitivityG D Nielsen, U Søderberg, P J Jørgensen, et al.
Blood|May 15, 1992
Reduction of tissue iron stores and normalization of serum ferritin during treatment with the oral iron chelator L1 in thalassemia intermediaN F Olivieri, G Koren, D Matsui, et al.
Bone Marrow Transplantation|January 1, 1993
Oral iron chelation with 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron loaded thalassemia patientsN F Olivieri, D Matsui, P P Liu, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1992
Growth failure and bony changes induced by deferoxamineN F Olivieri, G Koren, J Harris, et al.
The New England Journal of Medicine|August 13, 1998
Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia majorN F Olivieri, G M Brittenham, C E McLaren, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|June 1, 1996
Sample collection guidelines for trace elements in blood and urine. IUPAC Commission of ToxicologyR Cornelis, B Heinzow, R F Herber, et al.
Blood|April 15, 1994
Iron-balance and dose-response studies of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron-loaded patients with sickle cell diseaseA F Collins, F F Fassos, S Stobie, et al.
Lancet (London, England)|November 24, 1990
Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patientsN F Olivieri, G Koren, C Hermann, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Seminars in Hematology|April 1, 1990
Studies of the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one in thalassemia patientsN F Olivieri, G Koren, P St Louis, et al.
Annals of the New York Academy of Sciences|January 1, 1990
Evaluation of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron-loaded patientsN F Olivieri, D M Templeton, G Koren, et al.
Toxicology and Applied Pharmacology|January 12, 1999
Absorption and retention of nickel from drinking water in relation to food intake and nickel sensitivityG D Nielsen, U Søderberg, P J Jørgensen, et al.
Blood|May 15, 1992
Reduction of tissue iron stores and normalization of serum ferritin during treatment with the oral iron chelator L1 in thalassemia intermediaN F Olivieri, G Koren, D Matsui, et al.
Bone Marrow Transplantation|January 1, 1993
Oral iron chelation with 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron loaded thalassemia patientsN F Olivieri, D Matsui, P P Liu, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1992
Growth failure and bony changes induced by deferoxamineN F Olivieri, G Koren, J Harris, et al.
The New England Journal of Medicine|August 13, 1998
Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia majorN F Olivieri, G M Brittenham, C E McLaren, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|June 1, 1996
Sample collection guidelines for trace elements in blood and urine. IUPAC Commission of ToxicologyR Cornelis, B Heinzow, R F Herber, et al.
Blood|April 15, 1994
Iron-balance and dose-response studies of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron-loaded patients with sickle cell diseaseA F Collins, F F Fassos, S Stobie, et al.
Lancet (London, England)|November 24, 1990
Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patientsN F Olivieri, G Koren, C Hermann, et al.
Pageof 9